Tag: WHO
Makers of ORSL introduce WHO ORS in ready-to-drink format
The WHO ORS market in India is currently estimated to be worth ₹300 crores and is growing significantly, outpacing other hydration categories
With over 97% reduction, govt envisions India’s Malaria-free status by 2030
India exits from the WHO’s High Burden to High Impact group in 2024, signifying a turning point in its fight against Malaria
“Indian vaccine industry has a promising future”
Dr Krishna Ella, Executive Chairman, Bharat Biotech and President, IVMA shares his insights on the industry’s journey so far and the future potential.
WHO prequalifies Zydus’s Typhoid Vi Conjugate Vaccine, ZyVac® TCV
Company receives acceptability, in principle, for ZyVac® TCV making it eligible for purchase by United Nations procurement agencies
Molbio Diagnostics’ Truenat System revolutionizes TB diagnosis in Nigeria
India's Truenat technology cuts diagnostic time and accelerates treatment for TB and drug-resistant TB in high-burden regions
Mpox virus of West African Clade 2 confirmed in isolated patient...
The travel-related case is not part of the current global public health emergency; patient remains stable with no immediate risk to public
Workshop held on animal infectious disease prioritization in New Delhi
Alka Upadhyaya outlines plans to establish FMD-free zones in eight states for enhancing animal health and export opportunities
Following WHO alert, LANXESS counters Mpox threat with Rely+On Virkon
Effectiveness of Rely+On Virkon against Mpox pathogens scientifically proven
The George Institute for Global Health and WHO to host 15th...
The George Institute for Global Health and WHO brings together global experts to address injury and violence prevention strategies
Mpox virus outbreak: Health Minister reviews India’s preparedness
While there are no reported cases of Monkeypox in India as of now, JP Nadda discussed cautionary measures to be put in place to prevent and control the spread of the disease